Category Archives: CEO

New Cancer Findings Good News for Eric Lefkosky’s Tempus

The development of lung cancer is determined by both environmental and genetic factors. The most common environmental risk factor that is associated with lung cancer is smoking cigarettes. Therefore the contribution of both genes and smoking to the etymology of cancer made an exciting combination that was under research by a team under Dr. Yafang Li.

The Dartmouth research team identified three single-nucleotide polymorphisms (SNPs) in the human DNA that influence the human body in developing and fighting disease. The research team also conducted an interaction analysis for two SNP’s lung cancer risks for non-small cell. Another study was performed on the SNP the lung cancer risk for squamous cell. These three SNPs that the team picked out for their research are the possible biomarkers in screening for lung cancer and intervention.

The research was titled “Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in the Caucasian population.” The findings were released for publication in Carcinogenesis. The results only apply to the Caucasian population just because other ethnicities have different genetic variations from the Caucasians. The identified interaction effect will have to be repeated using the genotype from other people.

The SNPs that were studied helped to identify the level of risk to lung cancer depending on one’s smoking behavior. The findings will improve how individual risks to developing the lung cancer disease can be pinned down more accurately from their smoking behavior. This will in turn help oncologists use the most personalized treatment plan that will be predicted based on the individual’s prognosis.

The findings that have come to light on lung cancer risk concerning smoking behavior in Caucasians have been received well at Tempus. Tempus has been on the forefront in redefining the application of genome data in a clinical setting. The company has primarily built an operating system dedicated to fighting cancer. This unique organization was co-founded and is currently headed by Eric Lefkofsky. He is the author of Accelerated Disruption.

Eric Lefkosky is also a co-founding partner of a venture fund that invests in disruptive technology, Lightbank. He is the co-founder and the current chairman of the e-commerce marketplace Groupon. Eric also co-founded Uptake Technologies, which offer some of the world’s biggest industries a platform to carry out predictive analysis. He is a trustee of some institutions in Chicago. These include Lurie Children’s Hospital of Chicago, Industry and World Business Chicago and The Art Institute of Chicago.

https://www.facebook.com/eplefkofsky/

Luiz Carlos Trabuco Cappi A Leading Entrepreneur And CEO Of Bradesco

There are only a handful of executives in the Brazilian economy who have as much influence as the chief executive officer of Bradesco. The position of Bradesco bank CEO provides the mandate to oversee some of the biggest financial projects in the state. Luiz Carlos Trabuco Cappi is the current CEO of the bank. He is the fourth president of the bank, the other three were the bank’s founder, Amador Aguiar, the present chairperson of the board, Lázaro Brandão, and Márcio Cypriano.

Luiz Carlos Trabuco Cappi took office in early March 2009, at an immensely challenging time where the bank had just lost its position as the top private bank to it rival Itaú Unibanco. Itaú Unibanco had taken the lead having about R $ 150 billion in assets more than Bradesco. Bradesco would require to acquire several smaller banks to quickly recover the gap. However, the financial and economic difficulties that were being experienced in the country saw the bank resorting to organic growth. Maintaining market lead was vital to Bradesco’s honour and reputation, this loss of lead severely affected the bank’s board of directors.

Luiz Carlos Trabuco Cappi held the opinion that the firm’s main objective was not to be the top bank but rather, to provide the best services to the communities it served. However, in August 2015, the CEO navigated the most daring move by purchasing the HSBC Brazilian branch with Lázaro Brandão’s approval for US $ 5.2 billion. The acquisition of HSBC enabled Bradesco to instantaneously achieve the growth and expansion it would have taken it six years to organically achieve. This move placed the bank back in the fray for leadership in the private segment and saw Luiz Carlos Trabuco Cappi selected by Dinheiro as the Entrepreneur of the Year in Finance.

Bradesco’s CEO, Luiz Carlos Trabuco Cappi, strongly identifies with the bank’s corporate culture as he has worked for the bank for over 40 years during which, he has risen through all the hierarchical levels of the firm. He has worked in various strategic areas of Bradesco such as in the private pension and marketing sections. He started by working as a clerk at the bank’s agency in Marília in 1969 and by 1999 had risen to the position of executive vice-president at Bradesco Seguros. He served as the president of Bradesco Seguros between 2003 and 2009. His achievements as head of the insurance company earned him great recognition. One of his major achievements was that the firm doubled in size with its market share rising from 23% to 25%. Under his management, the institution’s contributions to the Bradesco’s profit increased from 26% to 35%.

Luiz Carlos Trabuco Cappi’s character has a lot in common with that of his predecessors. He does not portray extravagant outwards signs of wealth. His suits are discreet, and he is soft spoken with a fine sense of humour and a broad smile. Unlike the majority of Bradesco’s managerial staff who have degrees in fields such as economics, administration, accounting, and engineering, the CEO is a philosophy graduate from the University of São Paulo. He undertook his postgraduate studies at the School of Sociology and Politics of São Paulo where he studied socio-psychology.

Luiz Carlos Trabuco Cappi is respected for his hardworking and positive nature. He is a goal-oriented leader who applies wisdom and persistence to achieve the desired goals. His character and optimism have earned him various awards. He has received the title of Insurance Personality of the Year in both 2003 and 2007. He also earned Dinheiro’s Entrepreneur of the Year in Finance title in 2015. In his position, he has continued to spread positivity to the insurance market place and steer the bank to greater success.

Learn more about Luiz Carlos Trabuco Cappi: http://istoe.com.br/5442_NOVO+COMANDO/

How Logan Stout Is Involved In Leadership Programs

Logan Stout is a renowned businessman, entrepreneur, philanthropist, best-selling author, and speaker. He has founded businesses that have generated billions of dollars.

He is the proprietor of the IDLife, which was launched in May 2014. Stout has partnered with Troy Aikman, Darwin Deason, and Jen Widerstorm in running the firm. He has also collaborated with various authors and fitness professional to create awareness to the public about the benefits of health and wellness. IDLife was named as one of the top100 Solid Top MLM Companies.

IDLife is a company that has specialized in the provision of health and wellness products. The firm is recognized for offering the best personalized nutritional assessment services that have transformed the lives of many people. The vitamin and supplement sector generates more than $23 billion annually in the United States.

Stout is committed to assisting people in bettering their leadership abilities. He is the author of a best-selling book that he has named “Stout Advice: The Secrets to Building Yourself, People, and Teams.” Logan launched the book in 2013, and it has been encouraging many people who want to utilize the strength that they received from God. Two entrepreneurs who are on ABC’s Shark Tank, Barbara Corcoran and Daymond John, endorsed his book. Stout has been to 196 countries where he has held leadership and personal growth training programs with a top motivational speaker who is known as John C. Maxwell. The Inc. Magazine named Maxwell as the “Most Popular Leadership Expert in the World.”

Another the major organization that Stout has established is Dallas Patriots baseball. He currently acts as the foundation’s CEO and has been using it in mentoring and guiding the youth. Dallas Patriots have been engaging persons who are between six and eighteen years old. All its graduates have had a chance to play college baseball, and some have joined MLB. Logan has been invited to speak on television and radio shows as well as live events. He is currently based in Frisco, Texas where he lives with his wife. The couple has been participating charity work, and they are the founders of the Youth Athletes Foundation.

Follow @LoganStout

Clay Siegall: A Legend whose Passion for Finding Solutions to Cancer Has Hugely Impacted on the Lives of Many

Clay Siegall is a legend in his right for his unwavering commitment to finding solutions to the cancer menace. The founder of Seattle Genetics has spent close to 20 years of his life researching and developing therapies for the treatment and mitigation of cancer. INSPIRERY recently had a chance to interview the legend about his past career and future plans.

 

How the Idea of Starting Seattle Genetics Was Born

 

Clay told INSPIRERY that understanding how technology and medicine would be married to obtain solutions to diseases had been his childhood dream. When he was a student, a relative of his was diagnosed with cancer. The relative had to undergo a series of chemotherapies whose side effect was a severe anemia that became an even bigger threat than cancer. Clay saw the process as brutal and vowed to find alternative cancer treatment procedures. From that experience, the dream of starting Seattle Genetics was born. It was, however, to take several years to materialize.

 

Money and Profitability

 

Making money is always a motivation for anyone starting a venture and Clay is no exemption. He, however, explained that money was not his main motivation in establishing Seattle Genetics: finding solutions for cancer was. He acknowledged that the company earns him handsome revenue through, among other avenues, selling proprietary drugs and production partnerships. That notwithstanding, it took Seattle Genetics a whole decade before realizing its first significant profits. At one point during its first years, the company was faced with a stiff capital challenge that nearly brought it to its knees. Clay was, however, able to steer it past the crisis.

 

 

About Clay Siegall

 

Clay Siegall is a Zoologist by training, with a degree in the field from The University of Maryland. His foundation as a researcher was developed at George Washington University from where he did his doctoral research and graduated with a Ph.D. in Genetics.

 

Clay initiated Seattle Genetics in 1998, and he has since then been serving as CEO and lead researcher. In his position, he has led the company in developing several FDA-approved drugs and therapies. Brentuximab vedotin is among the therapies developed by Seattle Genetics